Global RNAi for Therapeutic Market Insights, Forecast to 2025

Publisher Name :
Date: 04-Mar-2019
No. of pages: 129
Inquire Before Buying

The global RNAi for Therapeutic market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the RNAi for Therapeutic market based on company, product type, end user and key regions.

This report studies the global market size of RNAi for Therapeutic in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of RNAi for Therapeutic in these regions.

This research report categorizes the global RNAi for Therapeutic market by top players/brands, region, type and end user. This report also studies the global RNAi for Therapeutic market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:

- Alnylam Pharmaceuticals

- Arbutus Biopharma (Tekmira)

- Arrowhead Research

- Dicerna Pharmaceuticals

- Mirna Therapeutics

- Quark Pharmaceuticals

- RXi Pharmaceuticals

- Silence Therapeutics

- Benitec Biopharma

- Miragen Therapeutics

- Sylentis

- Gradalis

- Sirnaomics

- Silenseed

- Arcturus Therapeutics

- Ariz Biopharma

- Celsion Corporation

- Ascletis Pharmaceuticals

Market size by Product

- siRNA

- miRNA

- shRNA

Market size by End User

- Cancer

- Cardiovascular

- HBV

- Other

Market size by Region

- North America

- - United States

- - Canada

- - Mexico

- Asia-Pacific

- - China

- - India

- - Japan

- - South Korea

- - Australia

- - Indonesia

- - Singapore

- - Malaysia

- - Philippines

- - Thailand

- - Vietnam

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Spain

- - Russia

- Central & South America

- - Brazil

- - Rest of Central & South America

- Middle East & Africa

- - GCC Countries

- - Turkey

- - Egypt

- - South Africa

The study objectives of this report are:

- To study and analyze the global RNAi for Therapeutic market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.

- To understand the structure of RNAi for Therapeutic market by identifying its various subsegments.

- To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

- Focuses on the key global RNAi for Therapeutic companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.

- To project the value and sales volume of RNAi for Therapeutic submarkets, with respect to key regions.

- To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of RNAi for Therapeutic are as follows:

- History Year: 2014-2018

- Base Year: 2018

- Estimated Year: 2019

- Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of RNAi for Therapeutic market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Global RNAi for Therapeutic Market Insights, Forecast to 2025

Table of Contents
1 Study Coverage
1.1 RNAi for Therapeutic Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global RNAi for Therapeutic Market Size Growth Rate by Product
1.4.2 siRNA
1.4.3 miRNA
1.4.4 shRNA
1.5 Market by End User
1.5.1 Global RNAi for Therapeutic Market Size Growth Rate by End User
1.5.2 Cancer
1.5.3 Cardiovascular
1.5.4 HBV
1.5.5 Other
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global RNAi for Therapeutic Market Size
2.1.1 Global RNAi for Therapeutic Revenue 2014-2025
2.1.2 Global RNAi for Therapeutic Sales 2014-2025
2.2 RNAi for Therapeutic Growth Rate by Regions
2.2.1 Global RNAi for Therapeutic Sales by Regions
2.2.2 Global RNAi for Therapeutic Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 RNAi for Therapeutic Sales by Manufacturers
3.1.1 RNAi for Therapeutic Sales by Manufacturers
3.1.2 RNAi for Therapeutic Sales Market Share by Manufacturers
3.1.3 Global RNAi for Therapeutic Market Concentration Ratio (CR5 and HHI)
3.2 RNAi for Therapeutic Revenue by Manufacturers
3.2.1 RNAi for Therapeutic Revenue by Manufacturers (2014-2019)
3.2.2 RNAi for Therapeutic Revenue Share by Manufacturers (2014-2019)
3.3 RNAi for Therapeutic Price by Manufacturers
3.4 RNAi for Therapeutic Manufacturing Base Distribution, Product Types
3.4.1 RNAi for Therapeutic Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers RNAi for Therapeutic Product Type
3.4.3 Date of International Manufacturers Enter into RNAi for Therapeutic Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
4.1 Global RNAi for Therapeutic Sales by Product
4.2 Global RNAi for Therapeutic Revenue by Product
4.3 RNAi for Therapeutic Price by Product
5 Breakdown Data by End User
5.1 Overview
5.2 Global RNAi for Therapeutic Breakdown Data by End User
6 North America
6.1 North America RNAi for Therapeutic by Countries
6.1.1 North America RNAi for Therapeutic Sales by Countries
6.1.2 North America RNAi for Therapeutic Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America RNAi for Therapeutic by Product
6.3 North America RNAi for Therapeutic by End User
7 Europe
7.1 Europe RNAi for Therapeutic by Countries
7.1.1 Europe RNAi for Therapeutic Sales by Countries
7.1.2 Europe RNAi for Therapeutic Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe RNAi for Therapeutic by Product
7.3 Europe RNAi for Therapeutic by End User
8 Asia Pacific
8.1 Asia Pacific RNAi for Therapeutic by Countries
8.1.1 Asia Pacific RNAi for Therapeutic Sales by Countries
8.1.2 Asia Pacific RNAi for Therapeutic Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific RNAi for Therapeutic by Product
8.3 Asia Pacific RNAi for Therapeutic by End User
9 Central & South America
9.1 Central & South America RNAi for Therapeutic by Countries
9.1.1 Central & South America RNAi for Therapeutic Sales by Countries
9.1.2 Central & South America RNAi for Therapeutic Revenue by Countries
9.1.3 Brazil
9.2 Central & South America RNAi for Therapeutic by Product
9.3 Central & South America RNAi for Therapeutic by End User
10 Middle East and Africa
10.1 Middle East and Africa RNAi for Therapeutic by Countries
10.1.1 Middle East and Africa RNAi for Therapeutic Sales by Countries
10.1.2 Middle East and Africa RNAi for Therapeutic Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa RNAi for Therapeutic by Product
10.3 Middle East and Africa RNAi for Therapeutic by End User
11 Company Profiles
11.1 Alnylam Pharmaceuticals
11.1.1 Alnylam Pharmaceuticals Company Details
11.1.2 Company Business Overview
11.1.3 Alnylam Pharmaceuticals RNAi for Therapeutic Sales, Revenue and Gross Margin (2014-2019)
11.1.4 Alnylam Pharmaceuticals RNAi for Therapeutic Products Offered
11.1.5 Alnylam Pharmaceuticals Recent Development
11.2 Arbutus Biopharma (Tekmira)
11.2.1 Arbutus Biopharma (Tekmira) Company Details
11.2.2 Company Business Overview
11.2.3 Arbutus Biopharma (Tekmira) RNAi for Therapeutic Sales, Revenue and Gross Margin (2014-2019)
11.2.4 Arbutus Biopharma (Tekmira) RNAi for Therapeutic Products Offered
11.2.5 Arbutus Biopharma (Tekmira) Recent Development
11.3 Arrowhead Research
11.3.1 Arrowhead Research Company Details
11.3.2 Company Business Overview
11.3.3 Arrowhead Research RNAi for Therapeutic Sales, Revenue and Gross Margin (2014-2019)
11.3.4 Arrowhead Research RNAi for Therapeutic Products Offered
11.3.5 Arrowhead Research Recent Development
11.4 Dicerna Pharmaceuticals
11.4.1 Dicerna Pharmaceuticals Company Details
11.4.2 Company Business Overview
11.4.3 Dicerna Pharmaceuticals RNAi for Therapeutic Sales, Revenue and Gross Margin (2014-2019)
11.4.4 Dicerna Pharmaceuticals RNAi for Therapeutic Products Offered
11.4.5 Dicerna Pharmaceuticals Recent Development
11.5 Mirna Therapeutics
11.5.1 Mirna Therapeutics Company Details
11.5.2 Company Business Overview
11.5.3 Mirna Therapeutics RNAi for Therapeutic Sales, Revenue and Gross Margin (2014-2019)
11.5.4 Mirna Therapeutics RNAi for Therapeutic Products Offered
11.5.5 Mirna Therapeutics Recent Development
11.6 Quark Pharmaceuticals
11.6.1 Quark Pharmaceuticals Company Details
11.6.2 Company Business Overview
11.6.3 Quark Pharmaceuticals RNAi for Therapeutic Sales, Revenue and Gross Margin (2014-2019)
11.6.4 Quark Pharmaceuticals RNAi for Therapeutic Products Offered
11.6.5 Quark Pharmaceuticals Recent Development
11.7 RXi Pharmaceuticals
11.7.1 RXi Pharmaceuticals Company Details
11.7.2 Company Business Overview
11.7.3 RXi Pharmaceuticals RNAi for Therapeutic Sales, Revenue and Gross Margin (2014-2019)
11.7.4 RXi Pharmaceuticals RNAi for Therapeutic Products Offered
11.7.5 RXi Pharmaceuticals Recent Development
11.8 Silence Therapeutics
11.8.1 Silence Therapeutics Company Details
11.8.2 Company Business Overview
11.8.3 Silence Therapeutics RNAi for Therapeutic Sales, Revenue and Gross Margin (2014-2019)
11.8.4 Silence Therapeutics RNAi for Therapeutic Products Offered
11.8.5 Silence Therapeutics Recent Development
11.9 Benitec Biopharma
11.9.1 Benitec Biopharma Company Details
11.9.2 Company Business Overview
11.9.3 Benitec Biopharma RNAi for Therapeutic Sales, Revenue and Gross Margin (2014-2019)
11.9.4 Benitec Biopharma RNAi for Therapeutic Products Offered
11.9.5 Benitec Biopharma Recent Development
11.10 Miragen Therapeutics
11.10.1 Miragen Therapeutics Company Details
11.10.2 Company Business Overview
11.10.3 Miragen Therapeutics RNAi for Therapeutic Sales, Revenue and Gross Margin (2014-2019)
11.10.4 Miragen Therapeutics RNAi for Therapeutic Products Offered
11.10.5 Miragen Therapeutics Recent Development
11.11 Sylentis
11.12 Gradalis
11.13 Sirnaomics
11.14 Silenseed
11.15 Arcturus Therapeutics
11.16 Ariz Biopharma
11.17 Celsion Corporation
11.18 Ascletis Pharmaceuticals
12 Future Forecast
12.1 RNAi for Therapeutic Market Forecast by Regions
12.1.1 Global RNAi for Therapeutic Sales Forecast by Regions 2019-2025
12.1.2 Global RNAi for Therapeutic Revenue Forecast by Regions 2019-2025
12.2 RNAi for Therapeutic Market Forecast by Product
12.2.1 Global RNAi for Therapeutic Sales Forecast by Product 2019-2025
12.2.2 Global RNAi for Therapeutic Revenue Forecast by Product 2019-2025
12.3 RNAi for Therapeutic Market Forecast by End User
12.4 North America RNAi for Therapeutic Forecast
12.5 Europe RNAi for Therapeutic Forecast
12.6 Asia Pacific RNAi for Therapeutic Forecast
12.7 Central & South America RNAi for Therapeutic Forecast
12.8 Middle East and Africa RNAi for Therapeutic Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 RNAi for Therapeutic Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables and Figures
Figure RNAi for Therapeutic Product Picture
Table RNAi for Therapeutic Market Segments
Table Key Manufacturers RNAi for Therapeutic Covered
Table Global RNAi for Therapeutic Market Size Growth Rate by Product 2019-2025 (K Units) & (Million US$)
Figure Global RNAi for Therapeutic Sales Market Share by Product 2014-2025
Figure siRNA Product Picture
Table Major Manufacturers of siRNA
Figure miRNA Product Picture
Table Major Manufacturers of miRNA
Figure shRNA Product Picture
Table Major Manufacturers of shRNA
Table Global RNAi for Therapeutic Market Size Growth Rate by End User 2019-2025 (K Units)
Figure Cancer
Figure Cardiovascular
Figure HBV
Figure Other
Figure RNAi for Therapeutic Report Years Considered
Figure Global RNAi for Therapeutic Market Size 2014-2025 (Million US$)
Figure Global RNAi for Therapeutic Sales 2014-2025 (K Units)
Table Global RNAi for Therapeutic Market Size by Regions 2014-2019 (K Units) & (Million US$)
Table Global RNAi for Therapeutic Sales by Regions 2014-2019 (K Units)
Table Global RNAi for Therapeutic Sales Market Share by Regions 2014-2019
Figure Global RNAi for Therapeutic Sales Market Share by Regions 2014-2019
Figure 2018 Global RNAi for Therapeutic Sales Market Share by Regions
Table Global RNAi for Therapeutic Revenue by Regions 2014-2019 (Million US$)
Table Global RNAi for Therapeutic Revenue Market Share by Regions 2014-2019
Figure Global RNAi for Therapeutic Revenue Market Share by Regions 2014-2019
Figure 2018 Global RNAi for Therapeutic Revenue Market Share by Regions
Table Global RNAi for Therapeutic Sales by Manufacturers (2014-2019) (K Units)
Table Global RNAi for Therapeutic Sales Share by Manufacturers (2014-2019)
Figure Global RNAi for Therapeutic Sales Share by Manufacturers in 2018
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table RNAi for Therapeutic Revenue by Manufacturers (2014-2019) (Million USD)
Table RNAi for Therapeutic Revenue Share by Manufacturers (2014-2019)
Figure RNAi for Therapeutic Value Share by Manufacturers in 2018
Table Key Manufacturers RNAi for Therapeutic Price (2014-2019) (USD/Unit)
Table RNAi for Therapeutic Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers RNAi for Therapeutic Product Type
Table Date of International Manufacturers Enter into RNAi for Therapeutic Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global RNAi for Therapeutic Sales by Product (2014-2019) (K Units)
Table Global RNAi for Therapeutic Sales Share by Product (2014-2019)
Figure Global RNAi for Therapeutic Sales Market Share by Product (2014-2019)
Figure Global RNAi for Therapeutic Sales Market Share by Product in 2018
Table Global RNAi for Therapeutic Revenue by Product (2014-2019) (Million US$)
Table Global RNAi for Therapeutic Revenue Share by Product (2014-2019)
Figure Global RNAi for Therapeutic Revenue Market Share by Product (2014-2019)
Figure Global RNAi for Therapeutic Revenue Market Share by Product in 2018
Table RNAi for Therapeutic Price by Product 2014-2019 (USD/Unit)
Table Global RNAi for Therapeutic Sales by End User (2014-2019) (K Units)
Table Global RNAi for Therapeutic Sales Share by End User (2014-2019)
Figure Global Sales RNAi for Therapeutic Market Share by End User (2014-2019)
Figure Global Sales RNAi for Therapeutic Market Share by End User in 2018
Figure North America RNAi for Therapeutic Sales Growth Rate 2014-2019 (K Units)
Figure North America RNAi for Therapeutic Revenue Growth Rate 2014-2019 (Million US$)
Table North America RNAi for Therapeutic Sales by Countries (2014-2019) (K Units)
Table North America RNAi for Therapeutic Sales Market Share by Countries (2014-2019)
Figure 2018 North America RNAi for Therapeutic Sales Market Share by Countries
Table North America RNAi for Therapeutic Revenue by Countries (2014-2019) (Million US$)
Table North America RNAi for Therapeutic Revenue Market Share by Countries (2014-2019)
Figure 2018 North America RNAi for Therapeutic Revenue Market Share by Countries
Figure United States RNAi for Therapeutic Sales Growth Rate (2014-2019) (K Units)
Figure United States RNAi for Therapeutic Revenue Growth Rate (2014-2019) (K Units)
Figure Canada RNAi for Therapeutic Sales Growth Rate (2014-2019) (K Units)
Figure Canada RNAi for Therapeutic Revenue Growth Rate (2014-2019) (Million US$)
Figure Mexico RNAi for Therapeutic Sales Growth Rate (2014-2019) (K Units)
Figure Mexico RNAi for Therapeutic Revenue Growth Rate (2014-2019) (Million US$)
Table North America RNAi for Therapeutic Sales by Product (2014-2019) (K Units)
Table North America RNAi for Therapeutic Sales Market Share by Product (2014-2019)
Figure 2018 North America RNAi for Therapeutic Market Share by Product
Table North America RNAi for Therapeutic Sales by End User (2014-2019) (K Units)
Table North America RNAi for Therapeutic Sales Market Share by End User (2014-2019)
Figure 2018 North America RNAi for Therapeutic Market Share by End User
Figure Europe RNAi for Therapeutic Sales Growth Rate 2014-2019 (K Units)
Figure Europe RNAi for Therapeutic Revenue Growth Rate 2014-2019 (Million US$)
Table Europe RNAi for Therapeutic Sales by Countries (2014-2019) (K Units)
Table Europe RNAi for Therapeutic Sales Market Share by Countries (2014-2019)
Figure 2018 Europe RNAi for Therapeutic Sales Market Share by Countries
Table Europe RNAi for Therapeutic Revenue by Countries (2014-2019) (Million US$)
Table Europe RNAi for Therapeutic Revenue Market Share by Countries (2014-2019)
Figure 2018 Europe RNAi for Therapeutic Revenue Market Share by Countries
Figure Germany RNAi for Therapeutic Sales Growth Rate (2014-2019) (K Units)
Figure Germany RNAi for Therapeutic Revenue Growth Rate (2014-2019) (Million US$)
Figure France RNAi for Therapeutic Sales Growth Rate (2014-2019) (K Units)
Figure France RNAi for Therapeutic Revenue Growth Rate (2014-2019) (Million US$)
Figure UK RNAi for Therapeutic Sales Growth Rate (2014-2019) (K Units)
Figure UK RNAi for Therapeutic Revenue Growth Rate (2014-2019) (Million US$)
Figure Italy RNAi for Therapeutic Sales Growth Rate (2014-2019) (K Units)
Figure Italy RNAi for Therapeutic Revenue Growth Rate (2014-2019) (Million US$)
Figure Russia RNAi for Therapeutic Sales Growth Rate (2014-2019) (K Units)
Figure Russia RNAi for Therapeutic Revenue Growth Rate (2014-2019) (Million US$)
Table Europe RNAi for Therapeutic Sales by Product (2014-2019) (K Units)
Table Europe RNAi for Therapeutic Sales Market Share by Product (2014-2019)
Figure 2018 Europe RNAi for Therapeutic Market Share by Product
Table Europe RNAi for Therapeutic Sales by End User (2014-2019) (K Units)
Table Europe RNAi for Therapeutic Sales Market Share by End User (2014-2019)
Figure 2018 Europe RNAi for Therapeutic Market Share by End User
Figure Asia Pacific RNAi for Therapeutic Sales Growth Rate 2014-2019 (K Units)
Figure Asia Pacific RNAi for Therapeutic Revenue Growth Rate 2014-2019 (Million US$)
Table Asia Pacific RNAi for Therapeutic Sales by Countries (2014-2019) (K Units)
Table Asia Pacific RNAi for Therapeutic Sales Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific RNAi for Therapeutic Sales Market Share by Countries
Table Asia Pacific RNAi for Therapeutic Revenue by Countries (2014-2019) (Million US$)
Table Asia Pacific RNAi for Therapeutic Revenue Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific RNAi for Therapeutic Revenue Market Share by Countries
Figure China RNAi for Therapeutic Sales Growth Rate (2014-2019) (K Units)
Figure China RNAi for Therapeutic Revenue Growth Rate (2014-2019) (Million US$)
Figure Japan RNAi for Therapeutic Sales Growth Rate (2014-2019) (K Units)
Figure Japan RNAi for Therapeutic Revenue Growth Rate (2014-2019) (Million US$)
Figure Korea RNAi for Therapeutic Sales Growth Rate (2014-2019) (K Units)
Figure Korea RNAi for Therapeutic Revenue Growth Rate (2014-2019) (Million US$)
Figure India RNAi for Therapeutic Sales Growth Rate (2014-2019) (K Units)
Figure India RNAi for Therapeutic Revenue Growth Rate (2014-2019) (Million US$)
Figure Australia RNAi for Therapeutic Sales Growth Rate (2014-2019) (K Units)
Figure Australia RNAi for Therapeutic Revenue Growth Rate (2014-2019) (Million US$)
Figure Indonesia RNAi for Therapeutic Sales Growth Rate (2014-2019) (K Units)
Figure Indonesia RNAi for Therapeutic Revenue Growth Rate (2014-2019) (Million US$)
Figure Malaysia RNAi for Therapeutic Sales Growth Rate (2014-2019) (K Units)
Figure Malaysia RNAi for Therapeutic Revenue Growth Rate (2014-2019) (Million US$)
Figure Philippines RNAi for Therapeutic Sales Growth Rate (2014-2019) (K Units)
Figure Philippines RNAi for Therapeutic Revenue Growth Rate (2014-2019) (Million US$)
Figure Thailand RNAi for Therapeutic Sales Growth Rate (2014-2019) (K Units)
Figure Thailand RNAi for Therapeutic Revenue Growth Rate (2014-2019) (Million US$)
Figure Vietnam RNAi for Therapeutic Sales Growth Rate (2014-2019) (K Units)
Figure Vietnam RNAi for Therapeutic Revenue Growth Rate (2014-2019) (Million US$)
Figure Singapore RNAi for Therapeutic Sales Growth Rate (2014-2019) (K Units)
Figure Singapore RNAi for Therapeutic Revenue Growth Rate (2014-2019) (Million US$)
Table Asia Pacific RNAi for Therapeutic Sales by Product (2014-2019) (K Units)
Table Asia Pacific RNAi for Therapeutic Sales Market Share by Product (2014-2019)
Figure 2018 Asia Pacific RNAi for Therapeutic Market Share by Product
Table Asia Pacific RNAi for Therapeutic Sales by End User (2014-2019) (K Units)
Table Asia Pacific RNAi for Therapeutic Sales Market Share by End User (2014-2019)
Figure 2018 Asia Pacific RNAi for Therapeutic Market Share by End User
Figure Central & South America RNAi for Therapeutic Sales Growth Rate 2014-2019 (K Units)
Figure Central & South America RNAi for Therapeutic Revenue Growth Rate 2014-2019 (Million US$)
Table Central & South America RNAi for Therapeutic Sales by Countries (2014-2019) (K Units)
Table Central & South America RNAi for Therapeutic Sales Market Share by Countries (2014-2019)
Figure 2018 Central & South America RNAi for Therapeutic Sales Market Share by Countries
Table Central & South America RNAi for Therapeutic Revenue by Countries (2014-2019) (Million US$)
Table Central & South America RNAi for Therapeutic Revenue Market Share by Countries (2014-2019)
Figure 2018 Central & South America RNAi for Therapeutic Revenue Market Share by Countries
Figure Brazil RNAi for Therapeutic Sales Growth Rate (2014-2019) (K Units)
Figure Brazil RNAi for Therapeutic Revenue Growth Rate (2014-2019) (Million US$)
Figure Argentina RNAi for Therapeutic Sales Growth Rate (2014-2019) (K Units)
Figure Argentina RNAi for Therapeutic Revenue Growth Rate (2014-2019) (Million US$)
Table Central & South America RNAi for Therapeutic Sales by Product (2014-2019) (K Units)
Table Central & South America RNAi for Therapeutic Sales Market Share by Product (2014-2019)
Figure 2018 Central & South America RNAi for Therapeutic Market Share by Product
Table Central & South America RNAi for Therapeutic Sales by End User (2014-2019) (K Units)
Table Central & South America RNAi for Therapeutic Sales Market Share by End User (2014-2019)
Figure 2018 Central & South America RNAi for Therapeutic Market Share by End User
Figure Middle East and Africa RNAi for Therapeutic Sales Growth Rate 2014-2019 (K Units)
Figure Middle East and Africa RNAi for Therapeutic Revenue Growth Rate 2014-2019 (Million US$)
Table Middle East and Africa RNAi for Therapeutic Sales by Countries (2014-2019) (K Units)
Table Middle East and Africa RNAi for Therapeutic Sales Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa RNAi for Therapeutic Sales Market Share by Countries
Table Middle East and Africa RNAi for Therapeutic Revenue by Countries (2014-2019) (Million US$)
Table Middle East and Africa RNAi for Therapeutic Revenue Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa RNAi for Therapeutic Revenue Market Share by Countries
Figure GCC Countries RNAi for Therapeutic Sales Growth Rate (2014-2019) (K Units)
Figure GCC Countries RNAi for Therapeutic Revenue Growth Rate (2014-2019) (Million US$)
Figure Turkey RNAi for Therapeutic Sales Growth Rate (2014-2019) (K Units)
Figure Turkey RNAi for Therapeutic Revenue Growth Rate (2014-2019) (Million US$)
Figure Egypt RNAi for Therapeutic Sales Growth Rate (2014-2019) (K Units)
Figure Egypt RNAi for Therapeutic Revenue Growth Rate (2014-2019) (Million US$)
Figure South Africa RNAi for Therapeutic Sales Growth Rate (2014-2019) (K Units)
Figure South Africa RNAi for Therapeutic Revenue Growth Rate (2014-2019) (Million US$)
Table Middle East and Africa RNAi for Therapeutic Sales by Product (2014-2019) (K Units)
Table Middle East and Africa RNAi for Therapeutic Sales Market Share by Product (2014-2019)
Figure 2018 Middle East and Africa RNAi for Therapeutic Market Share by Product
Table Middle East and Africa RNAi for Therapeutic Sales by End User (2014-2019) (K Units)
Table Middle East and Africa RNAi for Therapeutic Sales Market Share by End User (2014-2019)
Figure 2018 Middle East and Africa RNAi for Therapeutic Market Share by End User
Table Alnylam Pharmaceuticals Company Details
Table Alnylam Pharmaceuticals RNAi for Therapeutic Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Alnylam Pharmaceuticals Recent Development
Table Arbutus Biopharma (Tekmira) Company Details
Table Arbutus Biopharma (Tekmira) RNAi for Therapeutic Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Arbutus Biopharma (Tekmira) Recent Development
Table Arrowhead Research Company Details
Table Arrowhead Research RNAi for Therapeutic Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Arrowhead Research Recent Development
Table Dicerna Pharmaceuticals Company Details
Table Dicerna Pharmaceuticals RNAi for Therapeutic Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Dicerna Pharmaceuticals Recent Development
Table Mirna Therapeutics Company Details
Table Mirna Therapeutics RNAi for Therapeutic Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Mirna Therapeutics Recent Development
Table Quark Pharmaceuticals Company Details
Table Quark Pharmaceuticals RNAi for Therapeutic Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Quark Pharmaceuticals Recent Development
Table RXi Pharmaceuticals Company Details
Table RXi Pharmaceuticals RNAi for Therapeutic Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table RXi Pharmaceuticals Recent Development
Table Silence Therapeutics Company Details
Table Silence Therapeutics RNAi for Therapeutic Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Silence Therapeutics Recent Development
Table Benitec Biopharma Company Details
Table Benitec Biopharma RNAi for Therapeutic Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Benitec Biopharma Recent Development
Table Miragen Therapeutics Company Details
Table Miragen Therapeutics RNAi for Therapeutic Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Miragen Therapeutics Recent Development
Table Sylentis Company Details
Table Gradalis Company Details
Table Sirnaomics Company Details
Table Silenseed Company Details
Table Arcturus Therapeutics Company Details
Table Ariz Biopharma Company Details
Table Celsion Corporation Company Details
Table Ascletis Pharmaceuticals Company Details
Table Global RNAi for Therapeutic Sales Forecast by Regions 2019-2025 (K Units)
Table Global RNAi for Therapeutic Sales Market Share Forecast by Regions 2019-2025
Table Global RNAi for Therapeutic Revenue Forecast by Regions 2019-2025 (Million US$)
Table Global RNAi for Therapeutic Revenue Market Share Forecast by Regions 2019-2025
Table Global RNAi for Therapeutic Sales Forecast by Product 2019-2025 (K Units)
Table Global RNAi for Therapeutic Sales Market Share Forecast by Product 2019-2025
Table Global RNAi for Therapeutic Revenue Forecast by Product 2019-2025 (Million US$)
Table Global RNAi for Therapeutic Revenue Market Share Forecast by Product 2019-2025
Table Global RNAi for Therapeutic Sales Forecast by End User 2019-2025 (K Units)
Table Global RNAi for Therapeutic Sales Market Share Forecast by End User 2019-2025
Figure North America RNAi for Therapeutic Sales Growth Rate Forecast (2019-2025) (K Units)
Figure North America RNAi for Therapeutic Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Europe RNAi for Therapeutic Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Europe RNAi for Therapeutic Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Asia Pacific RNAi for Therapeutic Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Asia Pacific RNAi for Therapeutic Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Central & South America RNAi for Therapeutic Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Central & South America RNAi for Therapeutic Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Middle East and Africa RNAi for Therapeutic Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Middle East and Africa RNAi for Therapeutic Revenue Growth Rate Forecast (2019-2025) (Million US$)
Table RNAi for Therapeutic Value Chain
Table RNAi for Therapeutic Customers List
Table RNAi for Therapeutic Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
  • Global Antisense and RNAi Therapeutics Market 2020 by Company, Regions, Type and Application, Forecast to 2025
    Published: 24-Feb-2020        Price: US 3480 Onwards        Pages: 103
    Market Overview The global Antisense and RNAi Therapeutics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Antisense and RNAi Therapeutics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive......
  • Global Targeted RNA Sequencing Market Analysis 2015-2019 and Forecast 2020-2025
    Published: 23-Feb-2020        Price: US 2980 Onwards        Pages: 84
    Snapshot The global Targeted RNA Sequencing market size is estimated at xxx million USD with a CAGR xx% from 2015-2019 and is expected to reach xxx Million USD in 2020 with a CAGR xx% from 2020 to 2025. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Targeted RNA Sequencing by product, region and application, in addition, this report introduces market competition situation among the vendors ......
  • Global RNAi for Therapeutic Market Data Survey Report 2015-2025
    Published: 11-Feb-2020        Price: US 1500 Onwards        Pages: 61
    Summary RNA interference (RNAi) is a biological process in which RNA molecules inhibit gene expression, typically by causing the destruction of specific mRNA molecules. Historically, it was known by other names, including co-suppression, post-transcriptional gene silencing (PTGS), and quelling. Only after these apparently unrelated processes were fully understood did it become clear that they all described the RNAi phenomenon. RNAi is now known as precise, efficient, stable and be......
  • RNAi Therapeutics Market Insights 2019, Global and Chinese Analysis and Forecast to 2024
    Published: 09-Feb-2020        Price: US 3000 Onwards        Pages: 147
    RNAi Therapeutics Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global RNAi Therapeutics industry with a focus on the Chinese market. The report provides key statistics on the market status of the RNAi Therapeutics manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry. Overall, the report provides an in-depth insight of 2014-2024 global and Chinese RNAi Therape......
  • RNAi for Therapeutic Market Insights 2019, Global and Chinese Analysis and Forecast to 2024
    Published: 09-Feb-2020        Price: US 3000 Onwards        Pages: 148
    RNAi for Therapeutic Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global RNAi for Therapeutic industry with a focus on the Chinese market. The report provides key statistics on the market status of the RNAi for Therapeutic manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry. Overall, the report provides an in-depth insight of 2014-2024 global and Chinese RNA......
  • Antisense and RNAI Therapeutics Market Insights 2019, Global and Chinese Analysis and Forecast to 2024
    Published: 06-Feb-2020        Price: US 3000 Onwards        Pages: 143
    Antisense and RNAi Therapeutics Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Antisense and RNAi Therapeutics industry with a focus on the Chinese market. The report provides key statistics on the market status of the Antisense and RNAi Therapeutics manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry.Overall, the report provides an in-depth insight of ......
  • Global RNAi for Therapeutic Market Growth (Status and Outlook) 2020-2025
    Published: 21-Jan-2020        Price: US 3660 Onwards        Pages: 137
    According to this study, over the next five years the RNAi for Therapeutic market will register a 24.0% CAGR in terms of revenue, the global market size will reach $ 3515.2 million by 2025, from $ 1488.6 million in 2019. In particular, this report presents the global revenue market share of key companies in RNAi for Therapeutic business, shared in Chapter 3. This report presents a comprehensive overview, market shares and growth opportunities of RNAi for Therapeutic market by type......
  • Global RNAi for Therapeutic Market Analysis 2015-2019 and Forecast 2020-2025
    Published: 16-Jan-2020        Price: US 2980 Onwards        Pages: 83
    Snapshot RNA interference (RNAi) is a biological process in which RNA molecules inhibit gene expression, typically by causing the destruction of specific mRNA molecules. Historically, it was known by other names, including co-suppression, post-transcriptional gene silencing (PTGS), and quelling. Only after these apparently unrelated processes were fully understood did it become clear that they all described the RNAi phenomenon. RNAi is now known as precise, efficient, stable and b......
  • Global Targeted RNA Sequencing Market Research Report 2020
    Published: 02-Jan-2020        Price: US 2900 Onwards        Pages: 93
    Targeted RNA-sequencing (RNA-Seq) is a highly accurate method for selecting and sequencing specific transcripts of interest and offers both quantitative and qualitative information. Targeted RNA-Seq can be achieved via either enrichment or amplicon-based approaches, both of which enable gene expression analysis in a focused set of genes of interest, with enrichment assays also providing the ability to detect both known and novel gene fusion partners in many sample types. Targeted RNA-sequ......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs